MedTrace Logo

Bioavailability Study of Cretan Carob

NCT05870930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-02-18

No results posted yet for this study

Summary

This is an interventional, open-label, single-group, bioavailability postprandial study. The aim of the study is to evaluate the bioavailability of phenolic compounds of a beverage prepared with Cretan carob powder of the Imera cultivar in healthy individuals after consumption.

Conditions

  • Healthy Diet

Interventions

OTHER

Carob beverage

Volunteers will consume 2 tablespoons of carob powder in 200mL drinking water.

Sponsors & Collaborators

  • Harokopio University

    lead OTHER

Principal Investigators

  • Andriana C Kaliora · Harokopio University of Athens, Greece

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-10
Primary Completion
2024-10-01
Completion
2025-03-01

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870930 on ClinicalTrials.gov